α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathwaysJulie K. Mason, Lilian U. Thompson|Lipids in Health and Disease|2015Cited by 35